 The two aims of the study are: 1 to demonstrate that the basement membrane glucose transporter 1 GLUT-1 is upregulated in the Roux limb following RYGB, and 2 to demonstrate that the upregulation of GLUT-1 is a major mechanism for the improvement in glycemic control observed in T2DM patients undergoing RYGB. 